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Abstract
Introduction: Left ventricular (LV) dysfunction is common in septic shock. Its association with the clinical outcome
is still controversial. Tissue Doppler imaging (TDI) is a useful tool to quantify LV function; however, little knowledge
is available about the prognostic value of these TDI variables in septic shock. Therefore, we performed this
prospective study to determine the role of TDI variables in septic shock.
Methods: Patients with septic shock in a medical intensive care unit were studied with transthoracic
echocardiography with TDI within 24 hours after the onset of septic shock. Baseline clinical, laboratory, and
echocardiographic variables were prospectively collected. Independent predictors of 90-day mortality were
analyzed with the Cox regression model.
Results: During a 20-month period, 61 patients were enrolled in the study. The 90-day mortality rate was 39%; the
mean APACHE IV score was 84 (68 to 97). Compared with survivors, nonsurvivors exhibited significantly higher
peak systolic velocity measured at the mitral annulus (Sa) (11.0 (9.1 to 12.5) versus 7.8 (5.5 to 9.0) cm/sec; P <
0.0001), lower PaO2/FiO2 (123 (83 to 187) versus 186 (142 to 269) mm Hg; P = 0.002], higher heart rate (120 (90 to
140) versus 103 (90 to 114) beats/min; P = 0.004], and ahigher dose of norepinephrine (0.6 (0.2 to 1.0) versus 0.3
(0.2 to 0.5) μg/kg/min; P = 0.007]. In the multivariate analysis, Sa > 9 cm/sec (hazard ratio (HR), 5.559; 95%
confidence interval (CI), 2.160 to 14.305; P < 0.0001), dose of norepinephrine (HR, 1.964; 95% CI, 1.338 to 2.883; P =
0.001), and PaO2/FiO2 (HR, 0.992; 95% CI, 0.984 to 0.999; P = 0.031) remain independent predictors of 90-day
mortality in septic-shock patients.
Conclusions: Our study demonstrated that LV systolic function as determined by TDI, in particular, Sa, might be
associated with mortality in patients with septic shock.
Introduction
Although left ventricular (LV) depression in sepsis was
first reported decades ago [1], it has not been well
recognized until the recent widespread use of echocar-
diography in the intensive care unit (ICU) [2]. A variety
of echocardiographic parameters have been developed to
assess LV function [3]. Among these parameters, ejec-
tion fraction (EF) is most commonly used to evaluate
LV systolic function, although studies exploring its asso-
ciation with clinical outcome have demonstrated con-
flicting results in high-risk patients, especially in
patients with septic shock [2].
Tissue Doppler imaging (TDI) has been shown to be
useful for quantifying global systolic and diastolic LV
function [4-6]. The peak systolic velocity measured at
the mitral annulus (Sa) reflects the long-axis systolic
motion of the ventricle, whereas the early diastolic velo-
city of the mitral annulus (Ea) reflects the rate of myo-
cardial relaxation. Both Sa and Ea have been
demonstrated as useful tools to predict prognosis in a
variety of cardiovascular diseases [7]. However, the
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prognostic value of the TDI variables in septic shock
requires further clarification.
Therefore, we performed a prospective, observational
study to evaluate the prognostic significance of TDI
variables in septic shock.
Materials and methods
Patients
The study was performed in a nine-bed medical ICU of
a university teaching hospital. Between January 2010
and August 2011, all patients admitted for septic shock
that developed within 24 hours before ICU admission
were prospectively screened for eligibility. Sepsis, severe
sepsis, and septic shock were defined according to con-
sensus definition [8] (see Additional file 1 Figure S2),
and the differentiation between infectious and noninfec-
tious etiologies was made at the discretion of the ICU
consultant. In patients with multiple episodes of septic
shock, only the first episode was included in this study.
Exclusion criteria included age younger than 18 years;
pregnancy; presence of moderate to severe valvular
heart disease; patients or their relatives declined partici-
pation; suboptimal echocardiograms; postthoracic opera-
tion; documented myocardial infarction at any point in
the medical history; and a decision of withdraw or with-
hold life-sustaining therapy.
Baseline clinical variables during the first 24 hours
after admission (day 1) were collected prospectively,
including age, gender, comorbidities, hemodynamic
parameters, vasopressor or inotropic dose, Acute Phy-
siology and Chronic Health Evaluation (APACHE) IV
score [9], and Sequential Organ Failure Assessment
(SOFA) score [10].
Echocardiographic examination
Two-dimensional conventional Doppler echocardiogra-
phy and TDI studies were performed with commercially
available equipment (Vivid I; GE Vingmed Ultrasound,
Tirat Hacarmel, Israel). All studies were performed and
reviewed by cardiologists with advanced training in
echocardiography.
The transthoracic echocardiographic examination was
performed within 24 hours after the onset of septic
shock at the first day of ICU stay (day 1). LV end-dia-
stolic volume (LVEDV), LV end-systolic volume
(LVESV), and LV ejection fraction (LVEF) were assessed
by using the modified biplane Simpson equation in the
apical four- and two-chamber views, according to the
American Society of Echocardiography Guidelines [11].
Mitral inflow was assessed with pulsed-wave Doppler
echocardiography from the apical four-chamber view.
The Doppler beam was aligned parallel to the direction
of flow, and a 1- to 2-mm sample volume was placed
between the tips of mitral leaflets during diastole [12].
From the mitral inflow profile, the E- and A-wave velo-
city and the E/A velocity ratio were measured. At least
three consecutive beats were measured, and the average
value was taken. In patients with tachycardia, the fused
EA wave was considered an E wave to calculate the E/
Ea.
TDI was performed at the apical four-chamber view
for the long-axis motion of the heart [13,14]. Two-
dimensional echocardiography with color-TDI imaging
was performed. The imaging angle was adjusted to
ensure a parallel alignment of the sampling window
with the myocardial segment of interest. Gain settings,
filters, pulse repetitive frequency, sector size, and depth
were adjusted to optimize color saturation. The frame
rate was adjusted to > 100. At least three consecutive
beats were stored, and the images were digitized and
analyzed off-line by EchoPac software (EchoPac 6.3.6;
Vingmed-General Electric, Horten, Norway). Pulse-Dop-
pler sample volume was placed at the septal and lateral
MV annulus to obtain the average value of systolic (Sa)
and early diastolic velocity (Ea) (see Additional file 1
Figure S2).
The intraobserver and interobserver variability in the
measurements of Sa were 1.8% and 4.2%, respectively.
Follow-up
Follow-up was performed for 90 days after the onset of
septic shock. The primary end point was 90-day all-
cause mortality, defined as death within 90 days after
onset of septic shock. Death was identified from hospital
records or telephone interviews with relatives.
The Institutional Review Board of Peking Union Med-
ical College Hospital approved this study protocol. Writ-
ten informed consent was obtained from either the
patients or their authorized relatives.
Statistical analysis
Deviations from a gaussian distribution were tested by
the Kolmogorov-Smirnov test. Continuous variables
were presented as median (25th to 75th percentiles).
Categoric variables were expressed as percentages of the
group from which they were derived. Continuous vari-
ables were compared with the use of the Student t test
or Mann-Whitney test. Categoric variables were com-
pared with the c2 test or Fisher Exact test. Linear
regression was used to investigate the correlation
between EF and Sa. A receiver-operating characteristic
(ROC) curve analysis was performed to determine the
cutoff value of Sa for the prediction of 90-day mortality.
The optimal cut-off value was defined as the point at
which the value of “sensitivity + specificity - 1” was
maximum (Youden index [15,16]).
A survival curve was performed by using the Kaplan-
Meier method, and mortality rates were compared
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according to the cut-off value of Sa by using the log-
rank test.
Cox proportional hazards regression model was used
to estimate the risk of death by multivariate analysis
(backward stepwise selection method with probability
for the removal of 0.10) for the whole population. The
multivariate analysis selection criterion from the univari-
ate analysis was P value < 0.05 and absence of collinear-
ity. Collinearity was defined as variance inflation factor
(VIF) > 10 by using linear regression analysis.
All analysis was performed by using software (SPSS
for Windows 11.5; SPSS, Chicago, IL, USA). Statistical
significance was considered at P < 0.05.
Results
Baseline characteristics
During the study period, from January 2010 to August
2011, 132 patients with septic shock were eligible for
assessment. Seventy-one were excluded in the final ana-
lysis, including consent refusal (n = 24), severe regurgi-
tation (n = 10), postthoracic operation (n = 5), withheld
or withdrawn therapy (n = 14), and suboptimal echocar-
diograms (n = 18). As a result, 61 patients were ana-
lyzed. Patients excluded had higher proportion of
coronary heart disease. No significant difference was
noted in other baseline characteristics between patients
excluded and included (see Additional file 1 Table S1).
The 33 (54%) men had a median age of 68 (52 to 77)
years, and an APACHE IV score of 84 (68 to 97).
Twenty-two patients died during ICU stay, and 24
patients died at 90 days after the onset of septic shock,
with a 90-day all-cause mortality of 39%. Five patients
died within 48 hours of ICU admission. A total of 36
(59%) patients had documented comorbidities, including
coronary heart disease (13%), hypertension (46%), and
diabetes (28%). For all patients, no episode of active
ischemia was documented in the last 3 months before
inclusion. The most common infection was pneumonia
(56%). All patients required vasoactive medications to
maintain blood pressure, and all were mechanically ven-
tilated because of acute lung injury. Table 1 compared
baseline clinical variables on ICU admission (day 1)
between survivors and nonsurvivors. Nonsurvivors had
significantly lower PaO2/FiO2 (123 (83 to 187) versus
186 (142 to 269) mm Hg; P = 0.002) than did survivors.
Table 2 summarized hemodynamic and echocardio-
graphic parameters on day 1. Heart rate was signifi-
cantly higher in nonsurvivors (120 (90 to 140) versus
103 (90 to 114) beats/min; P = 0.004]. Forty-nine (80%)
patients received norepinephrine infusion at a median
dose of 0.5 (0.2 to 0.7) μg/kg/min. The dose of norepi-
nephrine was significantly higher in nonsurvivors (0.6
(0.2 to 1.0) versus 0.3 (0.2 to 0.5) μg/kg/min; P = 0.007].
Twenty-seven (44%) patients were treated with
dopamine, the median dose being 6.0 (5.0 to 10.0) μg/
kg/min. During the study periods, one patient was trea-
ted with dobutamine (5 μg/kg/min), and another, with
epinephrine (0.5 μg/kg/min).
Echocardiographic variables
Five patients were in atrial fibrillation at the time of
echocardiography study. Ten of 61 patients had fused E
A wave, six in the group of survivors. Sa was signifi-
cantly lower in the survivors group than in the nonsur-
vivors (7.8 (5.5 to 9.0) versus 11.0 (9.1 to 12.5) cm/sec;
P < 0.0001), with a mean value of 9.0 (6.6 to 11.0) cm/
sec for the whole cohort. Sixteen (27%) patients had an
LVEF < 50%. LVEF values for survivors and nonsurvi-
vors were 56% (36% to 65%) and 63% (52% to 66%),
respectively. Other parameters, including those evaluat-
ing diastolic function, did not show any statistical differ-
ence between survivors and nonsurvivors (Table 2). A
moderate correlation between LVEF and Sa was identi-
fied with linear regression (Figure 1).
The ability of Sa to predict 90-day mortality according
to an ROC curve is shown in Figure 2, the area under
the curve being 0.83. With a cut-off value of 9 cm/sec,
the sensitivity and specificity of Sa to predict 90-day
mortality was 75% and 86%, respectively. Patients with a
higher Sa value (> 9 cm/sec) had a significantly higher
mortality rate (75% versus 17%; P < 0.0001; log-rank =
24.03; P < 0.0001) (Table 2 and Figure 3).
Predictors of 90-day mortality in septic shock patients
In the final multivariate analysis, Sa > 9 cm/sec
remained the strongest independent predictor of 90-day
mortality in septic shock patients (HR, 5.559; 95% CI,
2.160 to 14.305; Wald, 12.652; P < 0.0001). Moreover,
norepinephrine dose and PaO2/FiO2 were also indepen-
dent predictors, whereas heart rate did not exhibit any
predictive value. Subgroup analysis showed that, in
patients without a history of coronary heart disease, a Sa
value of > 9 cm/sec was still an independent predictor
of 90-day mortality (HR, 4.546; 95% CI, 1.749 to 11.819;
Wald, 9.651; P = 0.002) (Table 3).
Discussion
The major finding of our study was that increased Sa is
an independent predictor of 90-day mortality in patients
with septic shock.
In the landmark study of Parker et al. [1], 10 of the 20
patients with septic shock exhibited global hypokinesia
and ventricular dilation during the first 48 hours after
admission. Contrary to common sense, the authors
found significantly impaired LV systolic function in sur-
vivors compared with nonsurvivors. Subsequent studies
[17,18] demonstrated similar reversible global hypokine-
sia by echocardiography. Vieillard-Baron and colleagues
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[17] observed global hypokinesia in 26 of 67 patients.
Moreover, LVEF was compromised in survivors during
the first 24 hours (49% ± 18% versus 55% ± 15%) [17].
In another study performed over a period of 5 years
[18], survivors showed evidence of septic myocardial
dysfunction, as suggested by compromised LVEF (43.9%
± 16.4% versus 52.0% ± 14.0%) and higher LVEDV (75.3
± 20.1 ml/m2 versus 64.9 ± 25.0 ml/m2; P < 0.05). How-
ever, similar to our study, the difference in LVEF
between survivors and nonsurvivors was not significantly
different.
The linear correlation between Sa and ejection in our
study was similar to that of a previous study [5]. Unlike
LVEF, Sa was a sensitive marker of LV systolic function
in patients with cardiovascular disease, which showed
that Sa could predict clinical outcome in a more sensi-
tive manner than could the LVEF [7]. In a study of
hypertrophic cardiomyopathy, TDI revealed myocardial
contractive abnormalities before any clinical presenta-
tions [19]. In our study, Sa appeared to be a more-sensi-
tive predictor of mortality than was the ejection fraction.
However, the value of Sa remains to be validated in
more patient populations [7,19-21], especially in criti-
cally ill patients. Moreover, unlike patients with cardio-
vascular diseases in whom a lower Sa was associated
with lower survival rate, survivors with septic shock
exhibited significantly decreased Sa, as seen in our
study.
Many hypotheses have been proposed for myocardial
depression in septic shock [2,22]. However, most of
them could not explain why survivors exhibited more-
marked myocardial depression. Levy et al. [23] demon-
strated myocardial hibernation in sepsis by using mag-
netic resonance imaging, positron emission tomography,
and single-photon emission computed tomography ima-
ging. Myocardial hibernation is the best mechanism to








Age, years 68 (49-76) 74 (61-82) 0.167
Male, n (%) 18 (49) 15 (63) 0.289
BMI, kg/m2 23 (21-25) 23 (20-26) 0.732
APACHE IV score 79 (66-94) 93 (69-99) 0.339
APACHE IV predicted mortality, % 28 (17-53) 48 (35-61) 0.039
SOFA score 10 (8-12) 10 (8-12) 0.222
PaO2/FiO2, mm Hg 186 (142-269) 123 (83-187) 0.002
SOFA cardiovascular score 4 (4-4) 4 (4-4) 0.911
Days on vasoactive medications 5 (3-9) 7 (4-9) 0.340
ICU LOS, days 12 (8-22) 12 (4-20) 0.515
Hospital LOS, days 29 (17-49) 17 (6-52) 0.150
Comorbidities
Coronary heart disease, n (%) 6 (16) 2 (8) 0.373
Hypertension, n (%) 18 (49) 10 (42) 0.593
Diabetes, n (%) 12 (32) 5 (21) 0.324
Chronic renal failure, n (%) 6 (16) 2 (8) 0.373
Primary diagnosis of infection
Pneumonia, n (%) 18 (49) 16 (67) 0.166
Bacteremia, n (%) 5 (14) 2 (8) 0.535
Peritonitis, n (%) 5 (13) 1 (4) 0.231
Others, n (%) 9 (24) 5 (21) 0.751
Laboratory data
Lactate, mM 1.75 (1.30-2.88) 2.00 (1.80-3.98) 0.095
WBC, ×109/L 11.36 (7.18-19.99) 12.07 (6.91-18.90) 0.623
Procalcitonin, ng/ml 2.01 (0.59-7.40) 1.50 (0.53-5.71) 0.435
cTnI, μg/L 0.17 (0.06-1.14) 0.15 (0.04-0.93) 0.952
CKMB, μg/L 1.80 (0.60-3.83) 1.65 (1.03-4.90) 0.455
NTproBNP, pg/ml 4,072.00 (2,006.50-11,885.50) 3,710.00 (1,361.50-10,618.25) 0.693
APACHE, Acute Physiology And Chronic Health Evaluation; BMI, body mass index; Hospital LOS, hospital length of stay; SOFA, Sequential Organ Failure
Assessment.
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preserve cardiac myocytes by downregulation of oxygen
consumption and energy requirements. It is an adaptive
response to maintain myocardial viability for prevention
of cell-death pathway activation and to aid the future
full recovery. The slightly increased cardiac biomarkers
(that is, cTnI) in the study population also support that
physical myocardial injury is negligible. Instead, the
heart was injured “functionally.” Such a potential benefi-
cial response must be based on an assumption that tis-
sue perfusion might be maintained with the depressed
heart. With a close look at our data, lactate, a good
marker of tissue perfusion [24], was not elevated, despite
myocardial depression. However, serial echocardiographs
Table 2 Baseline hemodynamic and echocardiographic










Heart rate, beats/min 103 (90-114) 120 (90-140) 0.004
Mean arterial pressure, mm
Hg
76 (74-83) 74 (70-82) 0.189
Central venous pressure,
mm Hg
16 (12-17) 14 (11-19) 0.911
Dopamine, n (%) 17 (46) 10 (42)
Dose, μg/kg/min 5.0 (4.0-10.0) 6.0 (4.5-10.0) 0.836
Norepinephrine, n (%) 30 (81) 19 (79)
Dose, μg/kg/min 0.3 (0.2-0.5) 0.6 (0.2-1.0) 0.007









LVEDV, ml 72 (54-98) 63 (56-78) 0.110
LVESV, ml 30 (20-52) 26 (19-34) 0.169
LVEF biplane, % 56 (36-65) 63 (52-66) 0.111
LVEF biplane < 50%, n
(%)
12 (33) 4 (17) 0.234




Sa > 9 cm/s, n (%) 6 (17) 18 (75) <
0.0001
Diastolic parameters
E/A 0.9 (0.7-1.4) 0.7 (0.6-1.2) 0.171
Ea, cm/sec 8.3 (5.8-10.0) 7.0 (6.0-11.0) 0.634
Ea < 8 cm/sec, n (%) 15 (42) 12 (52) 0.429
E/Ea 11.1 (8.5-14.6) 11.1 (6.6-
14.1)
0.206
E, peak velocity of early diastolic transmitral flow; Ea, early diastolic velocity of
the mitral annulus; E/A, the ratio of mitral valve peak E-wave and peak A-
wave velocity; EDT, deceleration time of mitral E wave; LVEDV, left ventricular
end-diastolic volume; LVEF, left ventricle ejection fraction; LVESV, left
ventricular end-systolic volume; Sa, peak systolic velocity measured at mitral
annulus.
Figure 1 The line regression between left ventricular ejection
fraction (LVEF) and mitral annulus (Sa).
Figure 2 Receiver-operating characteristic (ROC) curve for
predicting 90-day mortality by using the peak systolic velocity
measured at the mitral annulus (Sa). Area under the curve is 0.83.
Figure 3 The 90-day mortality in the study population
classified according to the peak systolic velocity measured at
mitral annulus (Sa) < 9 cm/sec or Sa > 9 cm/sec.
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were performed for only some of our patients; further
serial study was warranted to support this hypothesis.
Persistent vasoplegia might be another explanation for
our finding. Although the Sa has advantages over pre-
viously used measures of LV systolic function, such as
LVEF, it still is load dependent, afterload especially
[25,26]. In the study of Robotham et al. [26], the same
level of LVEF may correspond to very different level of
intrinsic LV contractility. For instance, an LVEF of 55%
may correspond to severe impressed intrinsic LV con-
tractility in the presence of decreased vascular tone. It
would not be surprising to find relatively normal or
supernormal Sa in nonsurvivors in our study, which
reflected a hyperkinetic state associated with persistent
and profound vasoplegia that, in turn, could be a marker
of sustained cytokine release. This kind of persistent
vasoplegia was associated with a high mortality rate,
which is consistent with our findings.
Sturgess et al. [27] also reported the role of TDI to
assess LV function in septic shock patients. They failed
to find any difference in LV systolic function between
survivors and nonsurvivors. This might be explained by
the small sample size (n = 21) and high prevalence of
cardiac diseases (43%) in the study population. Myocar-
dial infarction may influence systolic and diastolic TDI
values, as previously described by Alam et al. [28]. We
also included patients with coronary heart disease in our
study, but patients with myocardial infarction were
excluded. Furthermore, after the exclusion of patients
with coronary heart disease, the predictive value of Sa
still remained. Similar to the study of Sturgess [27],
Landesberg et al. [29] did not find evidence of LV systo-
lic dysfunction in survivors. However, only 62% in the
study population had septic shock. This, in addition to
the imbalanced distribution of septic shock between sur-
vivors and nonsurvivors (57% versus 72%; P = 0.012),
precluded direct comparison between their study result
and that of our study.
In our cohort of patients, MAP was maintained at a
higher level than that recommended by the guideline
[30]. This can be explained by the high prevalence of
hypertension in the study population. Although no
evidence suggested the benefit of hyperdynamic support,
Dünser et al. [31] reported that the time spent below
the MAP of 75 mm Hg would increase the risk of sub-
sequent renal-replacement therapy. Such findings sug-
gest the importance of addressing ischemic acute renal
failure in the absence of frank hypotension [32]. Accord-
ingly, we try to individualize the target of blood pressure
in our patients, based on usual level. The study of Vieil-
lard-Baron et al. [17] suggested that the increased nore-
pinephrine loads necessary to maintain high blood
pressures were likely to cause LV hypokinesia. However,
the dose of norepinephrine to maintain blood pressure
in our groups was lower in survivors (0.3 (0.2 to 0.5)
versus 0.6 (0.2 to 1.0) μg/kg/min], who had a higher
incidence of LV hypokinesia. In the final multivariate
analysis, even after adjustment for norepinephrine treat-
ment, the prognostic value of Sa still attained statistical
significance.
Limitations
First, the sample size in our study was relatively small,
but the robust association between Sa and mortality rate
suggests that this was not just an accidental finding.
Possible selection biases might exist because more
patients were excluded than were studied. However, the
baseline characteristics, except for coronary heart dis-
ease, did not show significant differences between the
patients excluded and included. Second, this study is a
single-center study. Our local management strategy may
influence the patient’s outcome, which might preclude
the generalization of the study findings. Third, the
potential confounding factors for TDI variables were not
explored in this study. A more-detailed study focusing
on these confounding factors is highly desirable. Fourth,
correlation between TDI variables and blood flow-
derived parameters was not performed because pulmon-
ary artery catheters were inserted in only half of the
study population.
Conclusion
Our study demonstrated that LV systolic function, as
determined by TDI, in particular, by Sa, might be asso-
ciated with mortality in patients with septic shock. Con-
cerning the limitations as discussed earlier, further
studies are warranted to confirm our findings.
Key messages
• In patients with septic shock, compared with non-
survivors, survivors exhibited more marked myocar-
dial depression.
• Evaluation of LV function by TDI, in particular, by
Sa, might be associated with mortality in patients
with septic shock.
Table 3 Multivariate analysis for predictors of death in







PaO2/FiO2 0.992 (0.984-0.999) 4.628 0.031
Norepinephrine, μg/kg/
min
1.964 (1.338-2.883) 11.898 0.001
Sa > 9 cm/sec 5.559 (2.160-14.305) 12.652 <
0.0001
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